Lisa von Moltke
SVP Head of Clinical Development

Lisa von Moltke is Head of Clinical Development at Alkermes that includes Clinical Sciences and Medical Directors, Translational Medicine/Clinical Pharmacology, Medical Writing and DMPK/BA. Prior to joining Alkermes, Dr. von Moltke served as Vice President Clinical Pharmacology at Sanofi/Genzyme Corporation and was US Head Clinical & Exploratory Pharmacology Sciences (CEP) and Early Development. Starting from 2014 she was Head CEP for Japan and China regions. In 2006, Dr. von Moltke was Head, Translational Medicine for the Takeda Oncology Company in Cambridge, MA. She has served as President of the American College of Clinical Pharmacology, and as the Editor-in-Chief of The Journal of Clinical Pharmacology. Dr. von Moltke earned a Bachelor’s of Arts degree at Wellesley College and her Doctor of Medicine from Michigan State University, College of Human Medicine.